Daniel D. Von Hoff, MD, FAACR
Louis M. Weiner, MD
Nancy F. Goodman, JD
The American Association for Cancer Research (AACR) presented the Distinguished Public Service Award to three individuals for their work in preventing and curing all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research at the 2019 AACR Annual Meeting. Daniel D. Von Hoff, MD, FAACR; Louis M. Weiner, MD; and Nancy F. Goodman, JD, are being honored for their work in clinical research, scientific leadership, and cancer policy and advocacy.
Dr. Von Hoff received the 2019 AACR Distinguished Public Service Award in recognition of his clinical research career developing therapeutic agents and for his leadership in establishing the AACR/ASCO Methods in Clinical Cancer Research Workshop to educate and train young clinical investigators.
Dr. Von Hoff’s clinical work has helped develop many approved therapeutic agents, including docetaxel, gemcitabine, irinotecan, nab-paclitaxel, and paclitaxel. This current research is dedicated to identifying novel therapeutics that will target the most commonly mutated or dysregulated genes in lung and pancreatic cancers as well as hematologic malignancies.
Dr. Weiner has been awarded the 2019 AACR Distinguished Public Service Award in recognition of his work in developing and optimizing monoclonal antibody–based immunotherapies and for his contribution in establishing the AACR Cancer Immunology Task Force and AACR Cancer Immunology Working Group. His current work focuses on understanding why tumors become resistant to immunotherapies, with the goal of developing new treatments to overcome drug resistance.
Ms. Goodman received the 2019 AACR Distinguished Public Service Award in recognition of her outstanding leadership in cancer policy and advocacy.